Moreover, NRF2 silencing induces tumour growth retardation in mouse xenografts and a significant decrease in ErbB2 expression, a member of the human epidermal growth factor (EGF) receptor family that plays an essential role in cell proliferation and differentiation [75]. This evidence concerns the gene ERBB2 and neoplasm.